4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000018
Chief Medical Officer gave up 819 shares (to pay taxes)
- Chief Medical Officer acquired 2,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bowden Christopher · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-16 | Exercise or conversion : show line 1 in the form | +2,750 | 4,400 | D | ||
| 2020-02-18 | Shares withheld for taxes : show line 2 in the form | −819 | $52.01 | $42,596 | 3,581 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-14 | Grant or award : show line 3 in the form Restricted stock units | +12,000 | 12,000 | D |
| 2020-02-14 | Grant or award : show line 4 in the form Stock option (right to buy) | +45,000 | 45,000 | D |
| 2020-02-16 | Exercise or conversion : show line 5 in the form Restricted stock unit | −2,750 | 2,750 | D |
Loading xslF345X03/wf-form4_158214922111232.xml…